BiOnSil is a spin-off of the University of Milan-Bicocca, developing diagnostic and theranostic kits for the diagnosis of drug resistance in colorectal cancer; further down the product pipeline are also pharmacological inhibitors that could reduce carcinoma pharmacoresistance. The product platform is based on the researches of the team, that led to the identification of specific genes involved in drug resistance of colorectal cancer

Active Biotech AB engages in the development of pharmaceutical products. The firm specializes in the medical areas where the immune defense is of significant importance, including neurodegenerative diseases, autoimmune, inflammatory disease, and various forms of cancer. Its portfolio comprises orally active immunomodulatory molecules as well as antibody-based immunotherapy. The company was founded on June 15, 1982 and is headquartered in Lund, Sweden.

Roussel UCLAF.

Europroteome AG develops diagnostic, immunological, and prognostic tools as well as patient-specific therapies for human epithelial cancers.

Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom.

Hoechst Marion Roussel discovers, develops, manufactures, and sells proprietary and generic pharmaceutical products.

Proteome Sciences Plc engages in the applied proteomics and peptidomics services and applications. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. The company focuses on developing proprietary protein biomarkers for neurological diseases, oncology, and organ transplant rejection. Proteome Sciences was founded on December 10, 1993 and is headquartered in Addlestone, the United Kingdom.

Corion Biotech is a biotech company developing innovative therapeutic solutions for Women's Health. Its technology is based on a specific cell population derived from the human term placenta known as Placental Mesenchymal Stromal Cells (hPDMSCs).

Part of Amgen, Inc., Amgen Research (Munich) GmbH is a German company located in Munich. The firm produces copper and metal powders. Robert Saller and Peter Kufer are the current co-CEOs of the firm. On June 13, 2002 ECKA Granulate GmbH & Co. KG acquired Amgen Research (Munich) GmbH from Aurubis AG.

Develops pharmaceuticals

Beijing Zhikang Boyao Oncology Research Co. Ltd. operates medical oncology center for chemotherapy cancer patients. It engages in the research and development for cancer treatment and tumor transplantation through i-graft tumor transplantation model. The company was founded by Chen Yi You in December 2012 and is headquartered in Beijing, China.

The Istituto Superiore di Sanità (Italian National Institute of Health), also ISS, is an Italian public institution that, as the leading technical-scientific body of the Italian National Health Service (Servizio Sanitario Nazionale), performs research, trials, control, counseling, documentation and training for public health. The Institute is under the supervision of the Ministero della Salute (Ministry of Health).